Analyst firms · Wolfe Research · LHX
Wolfe Research LHX price target and rating history
L3Harris Technologies Inc. (LHX) · Industrials
Wolfe Research rates L3Harris Technologies Inc. (LHX) Outperform with a $300 price target, as of its latest action on Oct 10, 2024. It has published 4 rating actions on LHX since September 2021, including 2 upgrades and 0 downgrades. Across 5 firms with a LHX price target in the last 12 months, the median target is $348.
- Current rating
- Outperform
- Price target
- $300
- Median target, all firms
- $348
- Actions on LHX
- 4
Wolfe Research price target on LHX
Every Wolfe Research rating on LHX
- Oct 10, 2024
- Oct 11, 2022
- Jan 11, 2022
- Sep 8, 2021
How other firms rate LHX
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Citigroup | Buy | $348 | Nov 9, 2026 |
| Argus Research | Hold | Sep 25, 2026 | |
| Guggenheim | Buy | $365 | Sep 15, 2026 |
| Melius | Hold | Sep 8, 2026 | |
| Jefferies | Hold | $315 | Aug 26, 2026 |
| Morgan Stanley | Overweight | $367 | Dec 16, 2025 |
| BNP Paribas Exane | Neutral | $290 | Nov 18, 2025 |
Questions about Wolfe Research and LHX
- What is Wolfe Research's price target for LHX?
- Wolfe Research's latest stated price target for L3Harris Technologies Inc. (LHX) is $300, from its action on Oct 10, 2024.
- What is Wolfe Research's rating on LHX?
- Wolfe Research rates LHX Outperform, a bullish rating, as of Oct 10, 2024.
- When did Wolfe Research last change its view on LHX?
- On Oct 10, 2024, Wolfe Research upgrades to Outperform from Peer Perform, price target $300.
- How does Wolfe Research's LHX target compare with other analysts?
- Across 5 firms with a LHX price target in the last 12 months, the median target is $348.
More LHX rating histories
All Wolfe Research ratingsLHX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.